MedPath

A Study to evaluate the therapeutic effectiveness of selective Siddha Medicines – VeBSaM Therapy in the management of Cholelithiasis

Phase 2
Conditions
Health Condition 1: K802- Calculus of gallbladder without cholecystitis
Registration Number
CTRI/2024/06/069131
Lead Sponsor
ational Institute of Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Participants who were diagnosed Cholelithiasis by ultrasound scanning – size of the gallbladder stone between 3 to 10 mm.

Exclusion Criteria

1.Participants with comorbidities like renal failure and liver cirrhosis

2.Pregnant and lactating mother.

3.Severe Cholecystitis, Choledocholithiasis, Acute and Chronic Pancreatitis.

4.Participants with Gallstone present in neck of gall bladder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath